RPCG : (Amendment) Additional risk prevention measures in organizing the general meeting of shareholders for the year 2021,under the current circumstance of the Coronavirus 2019 Outbreak

-Translation-

No. RPCG/HO-SET/0005/2021

April 16, 2021

Subject: (Amendment) Additional risk prevention measures in organizing the general meeting of shareholders for the year 2021,under the current circumstance of the Coronavirus 2019 Outbreak

To: President

The Stock Exchange of Thailand

Reference is made to Board of Directors' Meeting No. 1/2021 of RPCG Public Company Limited ("the Company"), convened on 24 February 2021, which resolved to convene the 2021 Annual General Meeting of Shareholders on Friday 23, April 2021 at 13.30 hrs. at Auditorium Room, at 9th Fl. Shinawatra Tower III, 1010 Viphavadi Rangsit Rd., Chatuchak, Bangkok (the "Meeting"), to consider the important agenda as detailed in the Meeting's Notice that had already been sent to the Shareholders.

The Company has concerned on the current situation of COVID-19 outbreak. To conform with disease prevention measures and risk mitigation and safety to all shareholders amid the COVID-19 outbreak. The Company requests shareholders to grant proxy to independent directors instead of attending the meeting in person and no snacks and beverages, which may risk the infection of the disease.

As a result of the National Communicable Disease Committee on April 15, 2021 has considered the methods to prevent the spread of COVID-19 in many areas including Bangkok. To comply with such methods, the Company would like to revise the additional measures from the measures stated in the invitation letter as follows:

1. All shareholders/proxies who come to the Meeting must wear a face mask at all time and clean their hands frequently with alcohol gel.
2. Seats will be arranged with a distance of 1.5 meters between them. In addition, the company needs to arrange a meeting place with a social distancing. This will make the number of seats in the meeting room limited to about 50 seats. Including the directors and staff. There will be no additional seat for followers and if the seats are full, the Company reserves the right to not allow any more person to enter the meeting rooms. (First Come, First Served)
3. The Company reserves the right to not allow the following persons to attend the Meeting:
4. 1. The following group of persons:
   2. • Proven COVID-19 infected person (patients)
      • Person contacted with patients (person with high-risk exposure)
      • Person close to high-risk exposure persons
   3. Persons with the following symptoms:
   4. • Having a body temperature of 37.5 degrees Celsius or more
      • Having respiratory symptoms, such as coughing, sore throat, sneezing, runny nose, difficult breathing, or any other symptoms that indicate the potential COVID-19 infection
      • Refusing the screening process of the Company, including refusing to comply with other requirements of the Company
   5. Persons who travel, reside, or perform his duties in the maximum control area. This includes persons who was presented in crowded area with the COVID-19 outbreak.

-Translation-

1. The Company will not provide microphones for questioning in the meeting room. Participants who wish to ask questions will be requested to write down and send their questions to our officers. The Company will only answer the questions relevant to the agenda for voting in the meeting room. For other questions, the Company will consider as appropriate.
2. In case that shareholders wish to submit the questions related to the meeting agendas in advance by e-mail :[e-mail] 22 April 2021.
3. The Company will not allow for moving or changing the seat throughout the Meeting.
4. The Company will conduct the meeting concisely and speedily to limit the shareholders' and proxies' exposure time.

In the case that there are any changes to the situation or any additional requirements from government agencies, the Company will further notify the shareholders. The Company would like to thank all shareholders for strictly adhering to the abovementioned measures and apologize for any inconvenience that may arise.

Please be informed accordingly.

Yours faithfully,

(Mrs.Supannee Tanchaisrinakorn)

Company Secretary

Investor relation / Office of Managing Director

Email: [e-mail]. [phone]